Manuscript of RCA Presentation

We finished presentation about human security. Our area was "improve health and health service" and our presented recommendations were 7th and 8th recommendation. We divided three parts. First part presented Introduction, explain half of 8th recommendation, and conclusion. Second part presented 7th recommendation. Last part presented half of 8th recommendation. I was last part and here is my presentation manuscript.

In 8th recommendation, Ogata & Cell talk about intellectual property right hindering health security. In this section there are two important terms which are “intellectual property right” and “Generic drug”. Firstly, I will explain those terms.

First, what is “intellectual property right”?

Intellectual property rights are the rights given to creators.This right prevents other people from copying the inventor’s creations and usually creators can monopolize the creation for a certain period of time.

“Generic drug”

”Generic drug” is a drug that is not produce under the right of Intellectual property right. This is cheaper drugs. This drug is very cheap because usually drugs protected by intellectual property rights for several years so drugs are expensive. But after expire the intellectual property rights, other people can make same drugs and sell them and those drugs are called “generic drug”. The generic drugs use same component such as original drug but it cheaper than original drug.

“intellectual property rights” and “Generic drug” are keywords of 8th recommendation.

Next, I will explain difficult sentence in the text. Please open ELA reader page 6, line 28. It says “A balance must be crafted to provide incentives for research and development but also equitable access to life-saving drugs for those unable to purchase technologies in the global marketplace”. I will explain underline part. Firstly, “research and development” means “developing drugs or medical technology”. Secondary, “equitable access to life-saving drugs for those unable to purchase technologies in the global marketplace” means “provide the drugs or medical technologies to developing countries which can not buy drugs and medical technologies”. Ogata & Cell insist these balance is important.

Next presenter will explain this balance more in detail.